New variant four times more contagious than Omicron

Reuters file photo

The number of coronavirus patients is on the rise again in several countries, including China, due to the outbreak of the new variant of the virus. The new variant can infect the patients within a very short time. The Directorate General of Health Services (DGHS) disclosed this information in a press conference on Sunday morning.

Ahmedul Kabir, additional director (administration) of DGHS, said a new variant of BF-5 (a sub-variant of omicron) variant named BF-7 had been identified in China. This sub-variant is stronger than Omicron.

This sub-variant can infect a number of people within a very short time. Therefore, the people, who haven’t administered the coronavirus vaccine, should get vaccinated as soon as possible.

He further said, “The new variant has been detected in India as well. Therefore, we have made arrangements for rapid antigen tests in all the ports. The people with symptoms are being taken into isolation. The Institute of Epidemiology Disease Control and Research (IEDCR) has been instructed to identify patients infected with the new virus through genome sequencing. Besides, the hospitals have been asked to remain prepared.”

Referring to the decisions taken by the National Technical Advisory Committee, Ahmedul Kabir said, “There is reluctance among the people in maintaining health guidelines nowadays. We have ordered the authorities concerned to take necessary initiative to grow consciousness among the people in this regard.”

Speaking regarding extending the expiry date of the vaccines, he said, “There is no scope of raising questions regarding extending the expiry date of the vaccines. We have done this after taking consent from the vaccine manufacturing company and approval from the relevant authorities.”

Abul Bashar Mohammed Khurshid Alam, director of the DGHS; Mohammad Shahidullah, president of the National Technical Advisory Committee on coronavirus and DGHS spokesperson Prof Nazmul Alam were among others present at the press conference.